Abeona Therapeutics (ABEO) Assets (2016 - 2025)
Historic Assets for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $231.1 million.
- Abeona Therapeutics' Assets rose 9163.38% to $231.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.1 million, marking a year-over-year increase of 9163.38%. This contributed to the annual value of $108.9 million for FY2024, which is 7019.94% up from last year.
- As of Q3 2025, Abeona Therapeutics' Assets stood at $231.1 million, which was up 9163.38% from $246.2 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Assets registered a high of $246.2 million during Q2 2025, and its lowest value of $38.8 million during Q3 2022.
- Over the past 5 years, Abeona Therapeutics' median Assets value was $79.6 million (recorded in 2021), while the average stood at $101.3 million.
- Its Assets has fluctuated over the past 5 years, first plummeted by 6743.29% in 2022, then skyrocketed by 15023.9% in 2024.
- Over the past 5 years, Abeona Therapeutics' Assets (Quarter) stood at $79.6 million in 2021, then dropped by 19.31% to $64.2 million in 2022, then fell by 0.33% to $64.0 million in 2023, then soared by 70.2% to $108.9 million in 2024, then surged by 112.15% to $231.1 million in 2025.
- Its Assets was $231.1 million in Q3 2025, compared to $246.2 million in Q2 2025 and $99.4 million in Q1 2025.